Biogen’s lack of insider buying and reduced R&D spending raise concerns, but its future growth prospects remain. Find out why ...

Biogen BIIB will report first-quarter 2025 results on May 1, before market open. In the last reported quarter, the company's ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

Sage Therapeutics is rated a Strong Buy due to its undervaluation, trading below cash holdings, and potential in its drug pipeline, especially Zuranolone. Biogen's $7.22 per share buyout offer ...

12:42 PM ESTHealth Care Biogen offers to buy out Sage Therapeutics Biogen offers to buy out Sage Therapeutics ...

Biogen Pharmachem Industries Ltd share price was down by -3.16% from the previous closing price of ₹0.95. Who are peers of Biogen Pharmachem Industries Ltd? The peers of Biogen Pharmachem ...

Robin Sage is the culmination exercise and has been the litmus test for Soldiers striving to earn the Green Beret for more than 40 years. U.S. Army photo by K. Kassens Facebook ...

Sage Future, a 501(c)(3) backed by Open Philanthropy, launched an experiment earlier this month tasking four AI models in a virtual environment with raising money for charity. The models ...

Please provide your email address to receive an email when new articles are posted on . An AI-powered wristband was more effective than a sham device in improving essential tremor. It could be ...

Sage Homes began building the Markwood apartments in Burlington back in 2022; those west 156 units were completed in phases last year at 623 W. Stevens Road in Burlington, just west of Interstate ...

Approvals of disease-modifying drugs such as Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla have given people with Alzheimer’s new options. The authorizations support the use of the medicines in ...